Vident Investment Advisory, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$499,992
-23.7%
101,213
-2.8%
0.02%
-36.0%
Q4 2022$654,953
-6.7%
104,126
+59.9%
0.02%
+8.7%
Q3 2022$702,000
-14.5%
65,131
-9.6%
0.02%
-8.0%
Q2 2022$821,000
+16.3%
72,016
-7.0%
0.02%
+38.9%
Q1 2022$706,000
-26.7%
77,457
+20.0%
0.02%
-28.0%
Q4 2021$963,000
-33.8%
64,547
+14.1%
0.02%
-43.2%
Q3 2021$1,454,000
-8.0%
56,579
-6.7%
0.04%
-8.3%
Q2 2021$1,581,000
-24.8%
60,621
+1.8%
0.05%
-32.4%
Q1 2021$2,103,000
+39.9%
59,5640.0%0.07%
+16.4%
Q4 2020$1,503,000
+31.4%
59,564
+96.3%
0.06%
+7.0%
Q3 2020$1,144,000
-26.6%
30,336
-16.7%
0.06%
-30.5%
Q2 2020$1,559,000
+46.5%
36,406
-33.5%
0.08%
+17.1%
Q1 2020$1,064,000
-27.0%
54,748
-2.4%
0.07%
-22.2%
Q4 2019$1,457,000
+1.3%
56,070
+6.1%
0.09%
-28.6%
Q3 2019$1,439,000
-1.4%
52,823
-2.8%
0.13%
+7.7%
Q2 2019$1,459,000
-14.9%
54,332
-8.4%
0.12%
+27.2%
Q1 2019$1,715,000
+5.0%
59,330
-2.2%
0.09%0.0%
Q4 2018$1,634,00060,6820.09%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders